Session 9: BTK directed Therapy in WM
The following abstracts represent the presentations given at IWWM-9 (Amsterdam-2016), Session 9: BTK directed Therapy in WM:
Session Chair: Meletious Dimopoulos (Greece)
Ibrutinib in previously treated WM patients: Update of PFS and OS Data L. Palomba (USA)
Ibrutinib in rituximab refractory WM patients M. Dimopoulos (Greece)
Somatic Variants that contribute to ibrutinib resistance in WM S. Treon (USA)
BgB-3111 in previously treated WM patients C. Tam (Australia)